| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | An immunologic portrait of cancer. | J Transl Med | 2011 | 1.50 |
| 2 | Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma. | Proc Natl Acad Sci U S A | 2011 | 1.20 |
| 3 | Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. | J Transl Med | 2011 | 1.15 |
| 4 | Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy. | Genes Cancer | 2013 | 0.98 |
| 5 | The stable traits of melanoma genetics: an alternate approach to target discovery. | BMC Genomics | 2012 | 0.95 |
| 6 | IRF5 gene polymorphisms in melanoma. | J Transl Med | 2012 | 0.86 |
| 7 | Melanoma NOS1 expression promotes dysfunctional IFN signaling. | J Clin Invest | 2014 | 0.81 |
| 8 | Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population. | Med Oncol | 2012 | 0.75 |